Back to Search
KURT JAECKLE, M.D.
M.D.
Neurology Physician
NPI: 1205825650IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
25MA09911100(NJ)
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
25MA09911100(NJ)ME80085(FL)
CMS Specialties
PrimaryNEUROLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment.
PMID 16769420·Semin Oncol·2006
6-review
Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.
PMID 16211890·Cancer Treat Res·2005
6-review
Neurological manifestations of neoplastic and radiation-induced plexopathies.
PMID 15637650·Semin Neurol·2004
6-review
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
PMID 12125986·J Neurooncol·2002
3-trial
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.
PMID 19307505·J Clin Oncol·2009
3-trial
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
PMID 19066728·J Neurooncol·2009
3-trial
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
PMID 18955445·J Clin Oncol·2008
3-trial
North Central Cancer Treatment Group--achievements and perspectives.
PMID 18929151·Semin Oncol·2008
6-review
Is there an association between meningioma and hormone replacement therapy?
PMID 18182668·J Clin Oncol·2008
8-other
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.
PMID 17108063·Neuro Oncol·2007
3-trial
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.
PMID 16273313·J Neurooncol·2006
4-observational
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status.
PMID 16639492·J Neurooncol·2006
3-trial
Removal of an orbital metallic foreign body to facilitate magnetic resonance imaging: technical case report.
PMID 16639311·Neurosurgery·2006
5-case
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
PMID 16626884·Int J Radiat Oncol Biol Phys·2006
3-trial
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
PMID 16533878·Neuro Oncol·2006
3-trial
Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response.
PMID 16525179·J Clin Oncol·2006
6-review
Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
PMID 17135644·J Clin Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4500 SAN PABLO RD S
JACKSONVILLE, FL 32224 - Phone
- (904) 953-2000
Quick Facts
- NPI
- 1205825650
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile